期刊
CHEMICAL COMMUNICATIONS
卷 59, 期 72, 页码 10789-10792出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d3cc03530a
关键词
-
Here, a salicylaldehyde-based reversible covalent inhibitor (A2) with moderate cellular activity against AURKA and prolonged residence time is reported. The inhibitor also shows significant non-covalent inhibition towards LRRK2. This multitarget kinase inhibitor may serve as a starting point for developing more potent, selective, and dual-targeting covalent kinase inhibitors against AURKA and LRRK2 for mitophagy.
Herein, we report a salicylaldehyde-based, reversible covalent inhibitor (A2) that possesses moderate cellular activity against AURKA with a prolonged residence time and shows significant non-covalent inhibition towards LRRK2. Our results indicated that this multitarget kinase inhibitor may be used as the starting point for future development of more potent, selective and dual-targeting covalent kinase inhibitors against AURKA and LRRK2 for mitophagy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据